Tumor progression mechanisms: Insights from the central immune regulation of tissue homeostasis (Review)
- Authors:
- Natalya Lisovska
- Nasrulla Shanazarov
-
Affiliations: Department of Chemotherapy, Center of Oncology, Cyber Clinic of Spizhenko, Kyiv 08112, Ukraine, Department of General Surgery, Medical Center Hospital of The President's Affairs Administration of The Republic of Kazakhstan, Astana 010000, Republic of Kazakhstan - Published online on: April 5, 2019 https://doi.org/10.3892/ol.2019.10218
- Pages: 5311-5318
-
Copyright: © Lisovska et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Jiang WG and Ablin RJ: Cancer metastasis, challenges, progress and the opportunities. Front Biosci (Elite Ed). 3:391–394. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kitamura T, Qian BZ and Pollard JW: Immune cell promotion of metastasis. Nat Rev Immunol. 15:73–86. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Smith HA and Kang YT: The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl). 91:411–429. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Fridman WH, Pages F, Sautes-Fridman C and Galon J: The immune contexture in human tumours: Impact on clinical outcome. Nat Rev Cancer. 12:298–306. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zlotnic A and Yoshie O: The chemokine superfamily revisited. Immunity. 36:705–716. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Almeida FF and Belz GT: Innate lymphoid cells: Models of plasticity for immune homeostasis and rapid responsiveness in protection. Mucosal Immunol. 9:1103–1112. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Corrado C, Raimondo S, Chiesi A, Ciccia F, De Leo G and Alessandro R: Exosomes as intercellular signaling organelles involved in health and disease: Basic science and clinical applications. Int J Mol Sci. 14:5338–5366. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang CM, Ploia C, Anselmi F, Sarukhan A and Viola A: Adenosine triphosphate acts as a paracrine signaling molecule to reduce the motility of T cells. EMBO J. 33:1354–1364. 2014.PubMed/NCBI | |
|
Fidler IJ: Lymphocytes are not only immunocytes. Biomedicine. 32:1–3. 1980.PubMed/NCBI | |
|
Senovilla L, Galluzzi L, Zitvogel L and Kroemer G: Immunosurveillance as a regulator of tissue homeostasis. Trends Immunol. 34:471–481. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hu W and Pasare C: Location, location, location: Tissue-specific regulation of immune responses. J Leukoc Biol. 94:409–421. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shechter R, London A and Schwartz M: Orchestrated leukocyte recruitment to immune-privileged sites: Absolute barriers versus educational gates. Nat Rev Immunol. 13:206–218. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Schaerli P, Ebert L, Willimann K, Blaser A, Roos RS, Loetscher P and Moser B: A skin-selective homing mechanism for human immune surveillance T cells. J Exp Med. 199:1265–1275. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Satija R and Shalek AK: Heterogeneity in immune responses: From populations to single cells. Trends Immunol. 35:219–229. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Caramalho I, Nunes-Cabaco H, Foxall RB and Sousa AE: Regulatory T-cell development in the human thymus. Front Immunol. 6:3952015. View Article : Google Scholar : PubMed/NCBI | |
|
Ge Q, Hu H, Eisen HN and Chen J: Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments. Proc Natl Acad Sci USA. 99:2989–2994. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Chinn IK, Blackburn CC, Manley NR and Semprowski GD: Changes in primary lymphoid organs with aging. Semin Immunol. 24:309–320. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ucar O, Li K, Dvornicov D, Kreutz C, Timmer J, Matt S, Brenner L, Smedley S, Travis MA, Hoffman TG, et al: A thymic epithelial stem cell pool persists throughout ontogeny and is modulated by TGF-β. Cell Rep. 17:448–457. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Hsieh CS, Lee HM and Lio CW: Selection of regulatory T cells in the thymus. Nat Rev Immunol. 12:157–567. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Dobrzanski MJ: Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy. Front Oncol. 3:632013. View Article : Google Scholar : PubMed/NCBI | |
|
von Boehmer H: The thymus in immunity and in malignancy. Cancer Immunol Res. 2:592–597. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Dong J, Chen Y, Xu X, Jin R, Teng F, Yan F, Tang H, Li P, Sun X, Li Y, et al: Homeostatic properties and phenotypic maturation of murine CD4+ pre-thymic emigrants in the thymus. PLoS One. 8:e563782013. View Article : Google Scholar : PubMed/NCBI | |
|
Munoz MA, Biro M and Weninger W: T cell migration in intact lymph nodes in vivo. Curr Opin Cell Biol. 30:17–24. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Singh NK, Riley TP, Baker SCB, Borrman T, Weng Z and Baker BM: Emerging concepts in TCR specificity: Rationalizing and (maybe) predicting outcomes. J Immunol. 199:2203–2213. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Parrish HL, Deshpande NR, Vasic J and Kuhns MS: Functional evidence for TCR-intrinsic specificity for MHCII. Proct Natl Acad Sci USA. 113:3000–3005. 2016. View Article : Google Scholar | |
|
Sethna Z, Elhanati Y, Dudgeon CS, Callan CG Jr, Levine AJ, Mora T and Walczak AM: Insights into immune system development and function from mouse T-cell repertoires. Proc Natl Acad Sci USA. 114:2253–2258. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Muller WA: How endothelial cells regulate transmigration of leukocytes in the inflammatory response. Am J Pathol. 184:886–896. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Anders HJ, Romagnani P and Mantovani A: Pathomechanisms: Homeostatic chemokines in health, tissue regeneration, and progressive diseases. Trends Mol Med. 20:154–165. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Perals C, Leobon B, Fazilleau N, Joffre OP, Robey EA, et al: Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 16:628–634. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Farber DL, Yudanin NA and Restifo NP: Human memory T cells: Generation, compartmentalization and homeostasis. Nat Rev Immunol. 14:24–35. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Halkias J, Melichar HJ, Taylor KT and Robey EA: Tracking migration during human T cell development. Cell Mol Life Sci. 71:3101–3117. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Dominguez GA, Anderson NR and Hammer DA: The direction of migration of T-lymphocytes under flow depends upon which adhesion receptors are engaged. Integr Biol (Camb). 7:345–355. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Mrass P, Petravic J, Davenport MP and Weninger W: Cell-autonomous and environmental contributions to the interstitial migration of T cells. Semin Immunopathol. 32:257–274. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ruddle NH: Lymphatic vessels and tertiary lymphoid organs. J Clin Invest. 124:953–959. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Mai J, Virtue A, Shen J, Wang H and Yang XF: An evolving new paradigm: Endothelial cells-conditional innate immune cells. J Hematol Oncol. 6:612013. View Article : Google Scholar : PubMed/NCBI | |
|
Smigiel KS, Srivastava S, Stolley JM and Campbell DJ: Regulatory T-cell homeostasis: Steady-state maintenance and modulation during inflammation. Immunol Rev. 259:40–59. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Feinerman O, Jentsch G, Tkach KE, Coward JW, Hathorn MM, Sneddon MW, Emonet T, Smith KA and Altan-Bonnet G: Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response. Mol Syst Biol. 6:4372010. View Article : Google Scholar : PubMed/NCBI | |
|
Barbi J, Pardoll D and Pan F: Treg functional stability and its responsiveness to the microenvironment. Immunol Rev. 259:115–139. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhan Y, Bourges D, Dromey JA, Harrison LC and Lew AM: The origin of thymic CD4+CD25+ regulatory T cells and their co-stimulatory requirements are determined after elimination of recirculating peripheral CD4+ cells. Int Immunol. 19:455–463. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Mittelbrunn M and Sánchez-Madrid F: Intercellular communication: Diverse structures for exchange of genetic information. Nat Rev Mol Cell Biol. 13:328–335. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, Gonzalez S, Sanchez-Cabo F, González MÁ, Bernad A and Sanchez-Madrid F: Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commune. 2:2822011. View Article : Google Scholar | |
|
Azmi AS, Bao B and Sarkar FH: Exosomes in cancer development, metastasis, and drug resistance: A comprehensive review. Cancer Metastasis Rev. 32:623–642. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yáñez-Mó M, Siljander PR, Andreu Z, Zavec AB, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, et al: Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 4:270662015. View Article : Google Scholar : PubMed/NCBI | |
|
Green DR, Droin N and Pinkoski M: Activation-induced cell death in T cells. Immunol Rev. 193:70–81. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Ventimiglia LN and Alonso MA: Biogenesis and function of T cell-derived exosomes. Front Cell Dev Biol. 4:842016. View Article : Google Scholar : PubMed/NCBI | |
|
Tang Q, Jiang D, Harfuddin Z, Cheng K, Moh MC and Schwarz H: Regulation of myelopoiesis by CD137L signaling. Int Rev Immunol. 33:454–469. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Medler TR and Coussens LM: Duality of the immune response in cancer: Lessons learned from skin. J Invest Dermatol. 134:E23–E28. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Savage PA, Leventhal DS and Malchow S: Shaping the repertoire of tumor-infiltrating effector and regulatory T cells. Immunol Rev. 259:245–258. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Seyfried TN and Huysentruyt LC: On the origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Keskinov AA and Shurin MR: Myeloid regulatory cells in tumor spreading and metastasis. Immunobiology. 220:236–242. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kovács KA, Hegedus B, Kenessey I and Tímár J: Tumor type-specific and skin region-selective metastasis of human cancers: Another example of the ‘seed and soil’ hypothesis. Cancer Metastasis Rev. 32:493–499. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ben-Baruch A: Organ selectivity in metastasis: Regulation by chemokines and their receptors. Clin Exp Metastasis. 25:345–356. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Satelli A, Mitra A, Brownlee Z, Xia X, Bellister S, Overman MJ, Kopetz S, Ellis LM, Meng QH and Li S: Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 21:899–906. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Dasgupta A, Lim AR and Ghajar CM: Circulating and disseminated tumor cells: Harbingers or initiators of metastasis? Mol Oncol. 11:40–61. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Caceres G, Puskas JA and Magliocco AM: Circulating tumor cells: A window into tumor development and therapeutic effectiveness. Cancer Control. 22:167–176. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Caixeiro NJ, Kienzle N, Lim SH, Spring KJ, Tognela A, Scott KF, de Souza P and Becker TM: Circulating tumour cells-a bona fide cause of metastatic cancer. Cancer Metastasis Rev. 33:747–756. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sceneay J, Smyth MJ and Möller A: The pre-metastatic niche: Finding common ground. Cancer Metastasis Rev. 32:449–464. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Paduch R: The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol (Dordr). 39:397–410. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Coso S, Bovay E and Petrova TV: Pressing the right buttons: Signaling in lymphangiogenesis. Blood. 123:2614–2624. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pietras K and Östman A: Hallmarks of cancer: Interactions with the tumor stroma. Exp Cell Res. 316:1324–1331. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Spano D and Zollo M: Tumor microenvironment: A main actor in the metastasis process. Clin Exp Metastasis. 29:381–395. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Spinella F, Caprara V, Cianfrocca R, Rosanò L, Di Castro V, Garrafa E, Natali PG and Bagnato A: The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor. Carcinogenesis. 35:840–848. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Re RN and Cook JL: An intracrine view of angiogenesis. Bioessays. 28:943–953. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Egeblad M, Nakasone ES and Werb Z: Tumors as organs: Complex tissues that interface with the entire organism. Dev Cell. 18:884–901. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wolf D, Sopper S, Pircher A, Gastl G and Wolf AM: Treg(s) in cancer: Friends or foe? J Cell Physiol. 230:2598–2605. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Nishikawa H and Sakaguchi S: Regulatory T cells in tumor immunity. Int J Cancer. 127:759–767. 2010.PubMed/NCBI | |
|
Bhatia A and Kumar Y: Cellular and molecular mechanisms in cancer immune escape: A comprehensive review. Expert Rev Clin Immunol. 10:41–62. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Dyck L and Mills KHG: Immune checkpoints and their inhibition in cancer and infectious diseases. Eur J Immunol. 47:765–779. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Curiel TJ: Regulatory T cells and treatment of cancer. Curr Opin Immunol. 20:241–246. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
deLeeuw RJ, Kost SE, Kakal JA and Nelson BH: The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: A critical review of the literature. Clin Cancer Res. 18:3022–3029. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mailloux AW and Young MR: Regulatory T-cell trafficking: From thymic development to tumor-induced immune suppression. Crit Rev Immunol. 30:435–447. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
De Visser KE, Eichten A and Coussens LM: Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 6:24–37. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Quail DF and Joyce JA: Microenvironmental regulation of tumor progression and metastasis. Nat Med. 19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Josefowicz SZ, Lu LF and Rudensky AY: Regulatory T cells: Mechanisms of differentiation and function. Annu Rev Immunol. 30:531–564. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Struchko GY, Меrkulova LМ and Moskvichev YV: Morphological and immunohistochemical characteristics of the thymus during chemical carcinogenesis induced by 1,2-dimethylhydrazine administration. Morfologiia. 146:35–39. 2014.(In Russian). PubMed/NCBI | |
|
Hamidinia M, Ghafourian Boroujerdnia M, Talaiezadeh A, Solgi G, Roshani R, Iranprast S and Khodadadi A: Increased P-35, EBI3 transcripts and other Treg markers in peripheral blood mononuclear cells of breast cancer patients with different clinical stages. Adv Pharm Bull. 5:261–267. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lee JH, Chen Y, Chan JL, Qian YW and Goydos JS: Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction. Cancer Immunol Immunother. 60:685–692. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lagios MD: Clinical significance of immunohistochemically detectable epithelial cells in sentinel lymph node and bone marrow in breast cancer. J Surg Oncol. 83:1–4. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Vasco C, Canazza A, Rizzo A, Mossa A, Corsini E, Silvani A, Fariselli L, Salmaggi A and Ciusani E: Circulating T regulatory cells migration and phenotype in glioblastoma patients: An in vitro study. J Neurooncol. 115:353–363. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Kelaria S, Kerstetter J and Wang J: The functional and prognostic implications of regulatory T cells in colorectal carcinoma. J Gastrointest Oncol. 6:307–313. 2015.PubMed/NCBI | |
|
Protti MP, De Monte L and Di Lullo G: Tumor antigen-specific CD4+ T cells in cancer immunity: From antigen identification to tumor prognosis and development of therapeutic strategies. Tissue Antigens. 83:237–246. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X and Oppenheim JJ: Resolving the identity myth: Key markers of functional CD4+FoxP3+ regulatory T cells. Int Immunopharmacol. 11:1489–1496. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Ladoire S, Arnould L, Apetoh L, Coudert B, Martin F, Chauffert B, Fumoleau P and Ghiringhelli F: Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating Foxp3+ regulatory T cells. Clin Cancer Res. 14:2413–2420. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Teng MW, Ngiow SF, von Scheidt B, McLaughlin N, Sparwasser T and Smyth MJ: Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth. Cancer Res. 70:7800–7809. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Gu Y and Cao X: The exosomes in tumor immunity. Oncoimmunology. 4:e10274722015. View Article : Google Scholar : PubMed/NCBI | |
|
Bersanelli M and Buti S: From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis. World J Clin Oncol. 8:37–53. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Dolan DE and Gupta S: PD-1 pathway inhibitors: Changing the landscape of cancer immunotherapy. Cancer Control. 21:231–237. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Rei M, Pennington DJ and Silva-Santos B: The emerging protumor role of γδ T lymphocytes: Implications for cancer immunotherapy. Cancer Res. 75:798–802. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Pennock GK and Chow LQ: The evolving role of immune checkpoint inhibitors in cancer treatment. Oncologist. 20:812–822. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu J, Powis de Tenbossche CG, Cane S, Colau D, van Baren N, Lurquin C, Schmitt-Verhulst AM, Liljestrom P, Uyttenhove C and Van den Eynde BJ: Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes. Nat Commun. 8:14042017. View Article : Google Scholar : PubMed/NCBI |
